نمایش مختصر رکورد

dc.contributor.authorSon, Mai Hongen_US
dc.contributor.authorBieu, Bui Quangen_US
dc.contributor.authorHa, Le Ngocen_US
dc.date.accessioned1399-07-09T12:22:48Zfa_IR
dc.date.accessioned2020-09-30T12:22:48Z
dc.date.available1399-07-09T12:22:48Zfa_IR
dc.date.available2020-09-30T12:22:48Z
dc.date.issued2016-01-01en_US
dc.date.issued1394-10-11fa_IR
dc.date.submitted2015-07-30en_US
dc.date.submitted1394-05-08fa_IR
dc.identifier.citationSon, Mai Hong, Bieu, Bui Quang, Ha, Le Ngoc. (2016). Value of Dedicated Head and Neck 18F-FDG PET/CT Protocol in Detecting Recurrent and Metastatic Lesions in Post-surgical Differentiated Thyroid Carcinoma Patients with High Serum Thyroglobulin Level and Negative 131I Whole-body Scan. Asia Oceania Journal of Nuclear Medicine and Biology, 4(1), 12-18. doi: 10.7508/aojnmb.2016.04.003en_US
dc.identifier.issn2322-5718
dc.identifier.issn2322-5726
dc.identifier.urihttps://dx.doi.org/10.7508/aojnmb.2016.04.003
dc.identifier.urihttp://aojnmb.mums.ac.ir/article_5670.html
dc.identifier.urihttps://iranjournals.nlai.ir/handle/123456789/420876
dc.description.abstractObjective(s): In clinical practice, approximately 10-25% of post-surgical differentiated thyroid carcinoma (DTC) patients with high serum thyroglobulin (Tg) and negative <sup>131</sup>I whole-body scan (WBS) have poor prognosis due to recurrent or metastatic lesions after radioactive iodine treatment. The purpose of this study was to evaluate the value of <sup>18</sup>F-FDG PET/CT scan in DTC patients with high serum Tg level and negative 131I WBS.<br/>Methods: 69 post-surgical DTC patients with high serum Tg level and negative post ablation <sup>131</sup>I WBS were enrolled in this study. All DTC patients underwent head and neck ultrasound, CT scan and whole-body <sup>18</sup>F-FDG PET/CT, based on the dedicated head and neck protocol.<br/>Results: Overall, 92 lesions were detected in 43 (62.3%) out of 69 patients with positive <sup>18</sup>F-FDG PET/CT scan, compared to only 39 lesions detected on CT scan in 26 (37.7%) out of 69 patients. The sensitivity, accuracy and negative predictive value of <sup>18</sup>F-FDG PET/CT were 88%,87% and 76%, respectively, which were significantly higher than those of CT scan (67.2%, 54.3% and 48.8%, respectively) (P<0.01). Specificity and positive predictive value of <sup>18</sup>F-FDG PET/CT (90.5% and 95.2%, respectively) were similar to those of CT scan (95.2 % and 96.2 %, respectively) (P>0.05). The maximum standardized uptake value (SUV<sub>max</sub>) threshold was 4.5 with a good diagnostic value (sensitivity of 92.3 % and specificity of 100 %). The dedicated head and neck <sup>18</sup>F-FDG PET/CT protocol altered the treatment plan in 33 (47.8%) out of 69 DTC patients with high serum Tg level and negative 131I WBS.<br/>Conclusion: Dedicated head and neck <sup>18</sup>F-FDG PET/CT protocol showed a higher diagnostic value, compared to CT scan and played an important role in detecting recurrent or metastatic lesions in post-surgical DTC patients with high serum Tg level and negative <sup>131</sup>I WBS.en_US
dc.format.extent857
dc.format.mimetypeapplication/pdf
dc.languageEnglish
dc.language.isoen_US
dc.publisherAsia Oceania Federation of Nuclear Medicine & Biologyen_US
dc.relation.ispartofAsia Oceania Journal of Nuclear Medicine and Biologyen_US
dc.relation.isversionofhttps://dx.doi.org/10.7508/aojnmb.2016.04.003
dc.subject18F-FDG PET/CTen_US
dc.subjectDifferentiated Thyroid Carcinomaen_US
dc.subjectHead and necken_US
dc.subjectThyroglobulinen_US
dc.subjectThyroiden_US
dc.titleValue of Dedicated Head and Neck 18F-FDG PET/CT Protocol in Detecting Recurrent and Metastatic Lesions in Post-surgical Differentiated Thyroid Carcinoma Patients with High Serum Thyroglobulin Level and Negative 131I Whole-body Scanen_US
dc.typeTexten_US
dc.typeOriginal Articleen_US
dc.contributor.departmentDepartment of Nuclear Medicine, Tran Hung Dao Hospital, Hanoi, Vietnamen_US
dc.contributor.departmentDepartment of Nuclear Medicine, Tran Hung Dao Hospital, Hanoi, Vietnamen_US
dc.contributor.departmentDepartment of Nuclear Medicine, Tran Hung Dao Hospital, Hanoi, Vietnamen_US
dc.citation.volume4
dc.citation.issue1
dc.citation.spage12
dc.citation.epage18
nlai.contributor.orcid0000-0002-0554-0407


فایل‌های این مورد

Thumbnail

این مورد در مجموعه‌های زیر وجود دارد:

نمایش مختصر رکورد